News & Publications for:

Randall Bateman

Investigational drugs chosen for major Alzheimer’s prevention trial

Posted on October 12, 2012

DIAN Trials Unit study of families with inherited Alzheimer’s disease, using Gantenerumab, Solanezumab, and a beta-secretase inhibitor Read More

Posted in: HPAN, Neurodegeneration, Neurogenetics, News Faculty: ,

Bateman named Knight Distinguished Professor of Neurology

Posted on August 29, 2012

Research and clinical focus on Alzheimer’s disease Read More

Posted in: News Faculty:

Randall Bateman and colleagues describe Alzheimer’s timecourse

Posted on July 16, 2012

DIAN study shows that changes in familial Alzheimer’s disease are detectable up to 25 years before symptom onset Read More

Posted in: HPAN, Neurodegeneration, Neurogenetics, News, Therapeutics & Diagnostics Faculty: ,

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease

Posted on July 13, 2012

Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC; the Dominantly Inherited Alzheimer Network (2012). N Engl J Med, Epub Read More

Posted in: HPAN, Neurodegeneration, Neurogenetics, Publications, Therapeutics & Diagnostics Faculty: , , , , ,

Alison Goate, Randall Bateman featured in New York Times Magazine

Posted on June 11, 2012

An extended family’s history of Alzheimer’s disease, and participation in the DIAN study. Read More

Posted in: HPAN, Neurodegeneration, Neurogenetics, News, Therapeutics & Diagnostics Faculty: ,